Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Fluconazole 50 mg, 100 mg, 150 mg, 200 mg Capsules Pfizer Laboratoires SA., Amboise Cedex, France; and Pfizer Pty Limited, West Ryde, New South Wales, Australia Diflucan Fluconazole 2 mg/mL Infusion, solution Pfizer Laboratoires SA., Amboise Cedex, France Diflucan Flixotide 50 g/dose Inhaler, aerosol, metered Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom; and Glaxo Wellcome Production, Evreux, France Flixotide Adsorbed tetanus vaccine 10LfU/mL, diphtheria CRM protein conjugate 50 g/mL, diphtheria toxoid (adsorbed) 25LfU/mL, haemophilus influenzae type b vaccine 20 g/mL, pertussis vaccine (adsorbed) 32IOU Injection, suspension Lederle Laboratories, division of American Cyanamid Co., Pearl River, New York, United States of America Tetramune Dated this 3rd day of June 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.